Find a specialty clinic near youFind a clinic
FR

Frequently asked questions about Monovisc®

Monovisc® is manufactured from ultra-pure hyaluronic acid, which is a component of the synovial fluid of a healthy joint. When injecting this treatment, called viscosupplementation, the hyaluronic acid lubricates the cartilage, which is thought to relieve osteoarthritis pain by restoring the viscoelastic properties of the hyaluronic acid naturally found in the affected joint.
Monovisc® is indicated for the treatment of pain in osteoarthritis of the knee, hip, shoulder and ankle for patients who have failed to respond adequately to conservative non-pharmacology therapy and to simple analgesics, e.g., acetaminophen.
Monovisc® is administered by a doctor, trained in accepted injection techniques, through a single injection into the affected joint space.
Monovisc® has been shown to start providing relief of osteoarthritis knee pain as early as two weeks after injection. In the hip, shoulder and ankle, patients began to experience pain relief one month after injection.
Monovisc® has been shown to provide effective osteoarthritis pain relief for up to six months in the knee, hip, shoulder and ankle.
In the scientific studies associated with each joint, minimal side effects were reported. The only effects associated with Monovisc® were mild to moderate episodes of joint swelling, discomfort, and rashes.
Besides Monovisc®, there are other options available for osteoarthritis knee pain treatment, including the viscosupplements Cingal® and Orthovisc®. Learn more about other treatment options.
Yes. Doctors who can inject Monovisc® include orthopedic specialists, sports medicine specialists, and rheumatologists. Find a specialist near you.

Your partner
in orthopedic
pain relief

OSTEOARTHRITIS
Soft tissue
OSTEOARTHRITIS
Soft tissue